Parathyroid hormone regulates the distribution and osteoclastogenic potential of hematopoietic progenitors in the bone marrow

Journal of Bone and Mineral Research

Volumn 26, Issue 6, 2011, Pages 1207-1216

  Jacome Galarza, Christian E ^a   Lee, Sun Kyeong ^a   Lorenzo, Joseph A ^a   Aguila, Hector Leonardo ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Anabolic Response; Bone Remodeling; Osteoclast Progenitors; Osteoporosis; Parathyroid Hormone

Indexed keywords

ALENDRONIC ACID; COLONY STIMULATING FACTOR 1; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE[1-34]; STEM CELL FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELLULAR DISTRIBUTION; COMPETITIVE INHIBITION; CONTROLLED STUDY; CORTICAL BONE; EPIGENETICS; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HEMATOPOIETIC STEM CELL; HORMONAL REGULATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OSTEOCLASTOGENESIS; OSTEOLYSIS; PHENOTYPE; SPLEEN; TREATMENT DURATION;

ACID PHOSPHATASE; ANIMALS; BIOLOGICAL ASSAY; BONE MARROW CELLS; BONE RESORPTION; CATTLE; CELL DIFFERENTIATION; CELL SIZE; HEMATOPOIETIC STEM CELLS; ISOENZYMES; MALE; MICE; MICE, INBRED C57BL; OSTEOCLASTS; OSTEOGENESIS; PARATHYROID HORMONE; SPLEEN;

EID: 79958818085     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.324     Document Type: Article

References (38)

1. Walker DG,. Osteopetrosis cured by temporary parabiosis. Science. 1973; 180: 875.
2. Raisz LG,. Physiology and pathophysiology of bone remodeling. Clin Chem. 1999; 45: 1353-1358. (Pubitemid 29422075)
3. Teitelbaum SL,. Bone resorption by osteoclasts. Science. 2000; 289: 1504-1508.
4. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ,. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev. 1999; 20: 345-357. (Pubitemid 30649812)
5. Lorenzo J, Horowitz M, Choi Y,. Osteoimmunology: interactions of the bone and immune system. Endocr Rev. 2008; 29: 403-440. (Pubitemid 351831507)
6. Fuller K, Owens JM, Chambers TJ,. Induction of osteoclast formation by parathyroid hormone depends on an action on stromal cells. J Endocrinol. 1998; 158: 341-350. (Pubitemid 28407541)
7. Zaidi M,. Skeletal remodeling in health and disease. Nat Med. 2007; 13: 791-801. (Pubitemid 47038187)
8. Lupp A, Klenk C, Rocken C, Evert M, Mawrin C, Schulz S,. Immunohistochemical identification of the PTHR1 parathyroid hormone receptor in normal and neoplastic human tissues. Eur J Endocrinol. 2010; 162: 979-986.
9. Zhao W, Byrne MH, Boyce BF, Krane SM,. Bone resorption induced by PTH is strinkgly diminished in collagenase-resistant mutant mice. J Clin Invest. 1999; 103: 517-524. (Pubitemid 29094052)
10. Juppner H, Abou-Samra A, Freeman M, et al. A G Protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science. 1991; 254: 1024-1026. (Pubitemid 21917436)
11. Lee SK, Lorenzo JA,. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclasts-like cell formation. Endocrinology. 1999; 140: 3552-3561. (Pubitemid 30645409)
12. Schiller PC, D'Ippolito G, Roos BA, Howard GA,. Anabolic or catabolic responses of MC3T3-E1 osteoblastic cells to parathyroid hormone depend on time and duration of treatment. J Bone Miner Res. 1999; 14: 1504-1512. (Pubitemid 29416676)
13. Mohan S, Kutilek S, Zhang C, et al. Comparison of bone formation response to parathyroid hormone (1-34), (1-31), and (2-34) in mice. Bone. 2000; 27: 471-478.
14. Frolic CA, Black EC, Cain RL, et al. Anabolic and catabolic bone effects of human parathyroid hormone (1-34) are predicted by duration of hormone exposure. Bone. 2003; 33: 372-379. (Pubitemid 37103254)
15. Koh AJ, Demiralp B, Neiva KG, et al. Cells of the osteoclast lineage as mediators of the anabolic actions of parathyroid hormone in bone. Endocrinology. 2005; 146: 4584-4596. (Pubitemid 41446596)
16. Wang Y, Liu Y, Buhl K, Rowe DW,. Comparison of the action of transient and continuous PTH on primary osteoblast cultures expressing differentiation stage-specific GFP. J Bone Miner Res. 2005; 20: 5-14. (Pubitemid 41716213)
17. Li X, Liu H, Qin L, et al. Determination of dual effects of parathyroid hormone on skeletal gene expression in vivo by microarray and network analysis. J Biol Chem. 2007; 282: 33086-33097. (Pubitemid 350159330)
18. Pettway GJ, Meganck JA, Koh AJ, Keller ET, Goldstein SA, McCauley LK,. Parathyroid hormone mediates bone growth through the regulation of osteoblast proliferation and differentiation. Bone. 2008; 42: 806-818.
19. -/- mice. J Bone Miner Res. 2009; 24: 1586-1597.
20. Adams GB, Martin RP, Alley IR, et al. Therapeutic targeting of a stem cell niche. Nat Biotechnol. 2007; 25: 238-243. (Pubitemid 46227124)
21. Rodan GA, Martin TJ,. Therapeutic approaches to bone disease. Science. 2000; 289: 1508-1514.
22. Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001; 344: 1434-1441. (Pubitemid 32402100)
23. Cheng Z, Yao W, Zimmermann EA, Busse C, Ritchie RO, Lane NE,. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats. J Bone Miner Res. 2009; 24: 209-220.
24. Jacquin C, Gran DE, Lee S, Lorenzo JA, Aguila HL,. Identification of multiple osteoclast precursor populations in murine bone marrow. J Bone Miner Res. 2006; 21: 67-77. (Pubitemid 43023228)
25. Calvi LM, Adams GB, Weibrecht KW, et al. Osteoblastic cells regulate the hematopoietic stem cell niche. Science. 2003; 425: 841-846. (Pubitemid 37351468)
26. Spangrude GJ, Heimfeld S, Weissman IL,. Purification and characterization of mouse hematopoietic stem cells. Science. 1988; 241: 58-62.
27. + cells are the only stem cells in C57BL/Ka-Thy-1.1 bone marrow. J Exp Med. 1992; 175: 175-184.
28. Christensen JL, Weissman IL,. Flk-2 is a marker in hematopoietic stem cell differentiation: A simple method to isolate long-term stem cells. Proc Natl Acad Sci USA. 2001; 98: 14541-14546. (Pubitemid 33121428)
29. Kondo M, Weissman IL, Akashi K,. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell. 1997; 91: 661-672. (Pubitemid 27513657)
30. Jilka RL, O'Brien CA, Ali AA, Roberson PK, Weinstein RS, Manolagas SC,. Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts. Bone. 2009; 44: 275-286.
31. Brunner S, Zaruba M, Huber B, et al. Parathyroid hormone effectively induces mobilization of progenitor cells without depletion of bone marrow. Exp Hematol. 2008; 36: 1157-1166.
32. Zhang J, Niu C, Ye L, et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature. 2003; 425: 836-841. (Pubitemid 37351467)
33. Lo Celso C, Fleming HE, Wu JW, et al. Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche. Nature. 2009; 457: 92-96.
34. Van Beek ER, Lowik CWGM, Papapoulos SE,. Effect of alendronate treatment on the osteoclastogenic potential of bone marrow cells in mice. Bone. 1997; 20: 335-340. (Pubitemid 27196656)
35. Luckman SP, Hughes DE, Coxon FP, Russell GG, Rogers MJ,. Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. J Bone Miner Res. 1998; 13: 581-589. (Pubitemid 28163009)
36. Graham R, Russel G,. Bisphosphonates: Mode of Action and Pharmacology. Pediatrics. 2007; 119: S150-S162.
37. Amelio PD, Grimaldi A, Cristofaro MA, et al. Alendronate reduces osteoclast precursors in osteoporosis. Osteoporos Int. 2010; 21: 1741-1750.
38. Kollet O, Dar A, Lapidot T,. The multiple roles of osteoclasts in host defense: bone remodeling and hematopoietic stem cell mobilization. Annu Rev Immunol. 2007; 25: 51-69. (Pubitemid 46697902)